Name: Latest research reports of Cipla Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Cipla Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer

1504.1000 18.30 (1.23%)

NSE Aug 11, 2025 11:26 AM

Volume: 386.2K

Cipla Ltd.

30 Oct 2024

1504.10

1.23%

Cipla (SELL): No meaningful incremental triggers until Goa plant clearance

Sell: Cipla Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Earnings in line with our estimates on all fronts. However, US sales was down and 5% lower than our estimates in rupee terms

Cipla Ltd. has an average target of 1713.00 from 9 brokers.